diagnostic radiopharmaceutical

diagnostic radiopharmaceutical

a radioactive drug administered to a patient as a diagnostic tracer to differentiate normal from abnormal anatomical structures or biochemical or physiological functions. Most diagnostic radiopharmaceuticals emit gamma rays. A collimated external gamma-ray detector can determine the concentration of the drug in different organs and produce low-resolution images of the organs. Some radiopharmaceuticals, such as those prepared with tritium, carbon-14, or phosphorus-32, do not emit gamma rays. Their diagnostic use involves analyzing the concentration of the isotope in a metabolic end product in the patient's blood, urine, breath, or biopsy samples. For example, when glucose containing 14C is administered, the subsequent monitoring of 14CO2 in the patient's breath can indicate the absorption of glucose, its metabolism, and its elimination as a metabolic end product.
References in periodicals archive ?
Telix is developing an advanced portfolio of therapeutic and diagnostic radiopharmaceutical products addressing significant unmet medical needs in renal, prostate and brain (glioblastoma) cancer.
A longstanding product in its Global Medical Imaging business segment, Octreoscan imaging agent is a diagnostic radiopharmaceutical that is used to detect certain neuroendocrine tumors.
FDG is a diagnostic radiopharmaceutical with clinical applications in oncology, neurology and cardiology.
Contract notice: Diagnostic radiopharmaceutical supply of injectable solution (18 f) fludeoxyglucose for pet-ct studies in nuclear medicine services general hospital universitario santa luca de cartagena and the university hospital virgen de la arrixaca.
Eli Lilly and Company (NYSE: LLY) and its wholly owned subsidiary Avid Radiopharmaceuticals Inc announced on 19 October that they have received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in Europe recommending approval of Amyvid solution for injection as a diagnostic radiopharmaceutical indicated for Positron Emission Tomography imaging of beta-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment, who are being evaluated for Alzheimer's Disease and other causes of cognitive impairment.
Continuous supply of diagnostic radiopharmaceutical 18F-Fludeoxyglucose (FDG) (the goods) for the Department of Nuclear Medicine sponsor.
Contract notice:Supply of Diagnostic radiopharmaceutical
7 million doses, Tc-99m accounted for 80 percent of all diagnostic radiopharmaceutical injections2.
Prior Information Notice: Supply of diagnostic radiopharmaceutical 18f - fluorodeoxyglukosa (fdg), for positron emission tomography (pet).
5 million doses, Tc99m accounted for 82% of all diagnostic radiopharmaceutical injections.
Table 4: US Diagnostic Radiopharmaceutical Agents Market (2007 & 2009): Breakdown of Procedure Volume By Imaging Procedure - SPECT (Cardiac, Others) and PET (In Thousands) (includes corresponding Graph/Chart) II-30
Contract awarded for Diagnostic radiopharmaceutical Limulus Amebocyte Lysate Reagent Sensitivity 0.

Full browser ?